Results 91 to 100 of about 13,988 (233)

Responding With Evidence and Access for Childhood Headaches (REACH) study: A comparative effectiveness trial of cognitive behavioral therapy monotherapy versus combined cognitive behavioral therapy–pharmacotherapy with amitriptyline for the prevention of childhood migraine—The study protocol

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Migraine is one of the most common chronic health problems in children and adolescents, resulting in high levels of functional disability. Symptoms frequently persist into and impact the course of adulthood for affected individuals. Current practice recommendations include a combined therapy approach of preventive medication and cognitive ...
Estée C. H. Feldman, Michelle M. Ernst, Maya A. Marzouk, Robert C. Gibler, Brooke L. Reidy, Leigh A. Chamberlin, Megan Kirschman, James Peugh, Marielle Kabbouche, Susan L. LeCates, Joanne Kacperski, Jessica A. Saunders, Andrew D. Hershey, Marcy E. Yonker, Christina L. Szperka, Amy A. Gelfand, Scott W. Powers, on behalf of the REACH Study Investigators, Joanne Kacperski, Jennifer McVige, Frank Berenson, Chaouki Khoury, Judy Adelizzi‐Delany, Marcy Yonker, Elizabeth Ackley, J. Ivan Lopez, Ann Pakalnis, Sara Pavitt, Scott Turner, Elizabeth Doll, Michael Sowell, Rachel Evans, Lauren Evanczyk, Reena Rastogi, Amy Gelfand, Hannah Shapiro, Christina Szperka, Ankita Gosh, Rashmi Rao   +38 more
wiley   +1 more source

Gastroparesis

Canadian Medical Association Journal, 2023
Miles, Matthew, Woo, Matthew, Nasser, Yasmin   +2 more
openaire   +2 more sources

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Type 1 diabetes is defined by immune‐mediated beta‐cell failure and dependence on exogenous insulin. That definition is correct, but it may not fully describe many people seen in current clinical practice. Overweight and obesity are now common in type 1 diabetes, leading to variable combinations of high insulin requirement, hypertension ...
Zachary Bloomgarden
wiley   +1 more source

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Obesity Reviews, EarlyView.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani, Tzu‐Wen L. Cross, Erica de Jong, Emily S. Glover, Ivan D. Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D. Mattes   +8 more
wiley   +1 more source

Gastric peroral endoscopic myotomy for compassionate treatment of symptomatic gastroparesis in patients on chronic opioids

iGIE
Background and Aims: It has been estimated that nearly half of patients with gastroparesis use opioids long term, are unable to cease or wean opioid use, and continue to endorse debilitating symptoms.
Maham Hayat, MD, Abel Joseph, MD, Yasi Xiao, MD, Abdullah Abbasi, MD, Saurabh Chandan, MD, Sagar Pathak, MD, Baha Aldeen Bani Fawwaz, MD, Aimen Farooq, MD, Natalie Cosgrove, MD, Deepanshu Jain, MD, Mustafa A. Arain, MD, Kambiz Kadkhodayan, MD, Ernesto R. Gonzaga, MD, Irteza Inayat, MD, Muhammad K. Hasan, MD, Joo Ha Hwang, MD, Dennis Yang, MD   +16 more
doaj   +1 more source

Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers

Journal of Patient-Centered Research and Reviews, 2019
Gastroparesis is defined as a delay in gastric emptying in the absence of mechanical obstruction in the stomach. Gastroparesis has a number of causes, including postsurgical, secondary to medications, postinfectious, idiopathic, and as a complication of ...
Adam D. Farmer, Caroline Bruckner-Holt, Susanne Schwartz, Emma Sadler, Sri Kadirkamanthan   +4 more
doaj   +1 more source

Microbiome and Metabolomics in Obesity: Advances in Understanding and Interventions Across the Lifespan

Obesity Reviews, EarlyView.
ABSTRACT Obesity arises from intertwined and reciprocal diet‐microbiome‐host pathways that reshape energy balance, insulin sensitivity, and inflammation. This review synthesizes mechanistic links between microbial functions and metabolic control, charts lifestyle‐related lifecourse dynamics from birth to older age, examines how GLP‐1‐based therapies ...
Ioanna Panagiota Kalafati, David Krongauz, Alice Bosco, Antonio Noto, Cristina Piras, Maria Kafyra, Angelica Dessì, Matteo Mauri, Luigi Atzori, Adina Weinberger, Vassilios Fanos, George V. Dedoussis, on behalf of the BETTER4U consortium   +12 more
wiley   +1 more source

The role of diet in counteracting gastroparesis

, 2016
Gastroparesis is a syndrome characterized by delayed gastric emptying in the absence of mechanical obstruction. The most common symptoms associated with gastroparesis are early satiety, postprandial fullness, nausea and vomiting, but also abdominal ...
Santonicola, Antonella, Paola Iovino, Riccardo Marmo, Iovino, Paola, Marmo, Riccardo, Antonella Santonicola   +5 more
core   +1 more source

The Gastroparesis Patient: Medical and Surgical Treatment

, 2020
The diagnoses of gastroparesis has increased within the past several years. Gastroparesis symptoms are traditionally encountered first by the primary care provider.
Jones, Edward H., II
core   +1 more source

Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients

Transplant Infectious Disease, EarlyView.
Concomitant letermovir was associated with lower voriconazole exposure and reduced attainment of commonly used efficacy thresholds in lung transplant recipients. Routine therapeutic drug monitoring after letermovir initiation is recommended, and empiric voriconazole dose escalation may be needed to avoid subtherapeutic exposure. ABSTRACT Background The
Leah Georgiades, Sunish Shah, Erin K. McCreary, Fernanda Silveira, Raman Venkataramanan, Vignesh Vasudevan, Ryan M. Rivosecchi   +6 more
wiley   +1 more source